Salix matsudana Koidz. is a fast growing tree species. It has a high cadmium (Cd) tolerance capacity, making it potentially suitable for phytoremediation. Presently, transcriptomic and physiological Cd response mechanisms are poorly understood. Transcriptomic analysis in early response to high (50 μM) Cd levels was investigated in leaf and root of Cd-resistant S. matsudana Koidz.. Analysis of the response profiles demonstrate the existence of a complex transcriptional network in the root and leaf when exposed to Cd. The main response in the root involved up-regulation of genes associated with defence response via callose deposition in the cell wall and cell wall thickening. In the leaf, transcripts related to biotic stress signalling and secondary metabolism were activated. Additionally, many lignin and brassinosteroids synthesis pathway genes were induced mainly in the leaf, indicating that gene response to Cd was tissue-specific. The Cd transcriptome results were consistent with observed physiological changes. The sub-localization, transcriptional network, and physiological regulation demonstrate the tissue-specific manner of Cd response, and provide a novel insight into in early response of tree species to Cd exposure.
Bone tissue engineering is considered one of the pivotal treatments for bone defects in patients. However, the conventional strategies for repairing irregular and complex bone defects are highly unsatisfactory, and appropriate repairing of bone defects remains a challenge. In recent years, smart scaffolds integrated with multiple functions have emerged as promising alternatives for the treatment of various bone defects. In this study, 4D printed shape memory polymer (SMP) scaffolds containing bioactive fillers (hydroxyapatite and alendronate) and collagen–dexamethasone (Col–Dex) coating were fabricated, and their microstructures, porosity, mechanical properties, and biological functions were thoroughly investigated. The SMP scaffolds manufactured in this study could be programmed into temporary shapes of small sizes and then recovered to working sizes and shapes under an alternating magnetic field to fill bone defects. In addition, the biological studies including cytotoxicity tests, osteogenesis-related gene expressions, fluorescence staining imaging, and animal experiments demonstrated the effective biological activities and osteogenic effects of the 4D printed SMP scaffolds, with potential applications in bone tissue regeneration. In other words, the prepared 4D printed scaffolds with bioactive fillers and the Col–Dex coating will provide an efficient approach for personalized bone tissue repair as well as enhanced bone tissue regeneration.
4 December 2023 in International Journal of Pharmaceutics
This review summarizes advances in stimuli-responsive MOFs for natural medicine delivery and synergistic cancer therapy, emphasizing controlled release, combination strategies, and biosafety.
Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disorder that imposes a substantial healthcare burden globally. Recent advances highlight the potential of natural products in ameliorating T2DM. In this study, we investigated the therapeutic efficacy of nootkatone (Nok), a natural sesquiterpene ketone, in T2DM and elucidated its underlying mechanisms. In vivo experiments demonstrated that Nok administration markedly improved dysregulated glucose metabolism and ameliorated serum biochemical abnormalities in db/db mice. Leveraging a network pharmacology-based approach, we identified putative molecular targets of Nok. Subsequent in vitro analyses revealed that Nok significantly enhanced glucose consumption in cultured cells. Mechanistically, Nok robustly activated AMP-activated protein kinase (AMPK) while suppressing mitogen-activated protein kinase (MAPK) signaling. Western blot validation further indicated that Nok downregulated the phosphorylation of MAPK1/3 (ERK2/1), attenuating MAPK pathway activation and thereby alleviating metabolic dysfunction-associated fatty liver disease (MAFLD) progression in the diabetic model. Collectively, our findings suggest that Nok exerts anti-diabetic effects via dual modulation of AMPK activation and MAPK inhibition, effectively restoring metabolic homeostasis and mitigating inflammation in T2DM. This study positions Nok as a promising natural compound for therapeutic intervention in T2DM and associated metabolic disorders.